X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs SANOFI INDIA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD SANOFI INDIA STRIDES SHASUN LTD/
SANOFI INDIA
 
P/E (TTM) x 14.1 30.0 47.0% View Chart
P/BV x 1.9 5.3 36.0% View Chart
Dividend Yield % 0.5 1.7 32.1%  

Financials

 STRIDES SHASUN LTD   SANOFI INDIA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
SANOFI INDIA
Dec-16
STRIDES SHASUN LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,4134,560 31.0%   
Low Rs8484,400 19.3%   
Sales per share (Unadj.) Rs353.31,028.5 34.3%  
Earnings per share (Unadj.) Rs23.4129.0 18.1%  
Cash flow per share (Unadj.) Rs41.0186.0 22.0%  
Dividends per share (Unadj.) Rs5.0068.00 7.4%  
Dividend yield (eoy) %0.41.5 29.1%  
Book value per share (Unadj.) Rs320.4753.6 42.5%  
Shares outstanding (eoy) m89.3523.03 388.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.24.4 73.5%   
Avg P/E ratio x48.334.7 139.1%  
P/CF ratio (eoy) x27.624.1 114.5%  
Price / Book Value ratio x3.55.9 59.3%  
Dividend payout %21.452.7 40.6%   
Avg Mkt Cap Rs m100,988103,174 97.9%   
No. of employees `0004.73.6 129.5%   
Total wages/salary Rs m4,9883,592 138.9%   
Avg. sales/employee Rs Th6,730.06,537.7 102.9%   
Avg. wages/employee Rs Th1,063.6991.4 107.3%   
Avg. net profit/employee Rs Th445.5819.8 54.3%   
INCOME DATA
Net Sales Rs m31,56423,686 133.3%  
Other income Rs m1,212708 171.2%   
Total revenues Rs m32,77624,394 134.4%   
Gross profit Rs m5,2135,281 98.7%  
Depreciation Rs m1,5731,313 119.8%   
Interest Rs m1,80315 12,020.7%   
Profit before tax Rs m3,0494,661 65.4%   
Minority Interest Rs m1270-   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-3710-   
Tax Rs m6891,691 40.7%   
Profit after tax Rs m2,0892,970 70.4%  
Gross profit margin %16.522.3 74.1%  
Effective tax rate %22.636.3 62.2%   
Net profit margin %6.612.5 52.8%  
BALANCE SHEET DATA
Current assets Rs m35,94915,673 229.4%   
Current liabilities Rs m19,4026,678 290.5%   
Net working cap to sales %52.438.0 138.1%  
Current ratio x1.92.3 78.9%  
Inventory Days Days7176 93.3%  
Debtors Days Days12722 568.3%  
Net fixed assets Rs m34,4788,098 425.8%   
Share capital Rs m894230 388.0%   
"Free" reserves Rs m22,60117,088 132.3%   
Net worth Rs m28,63217,356 165.0%   
Long term debt Rs m27,4550-   
Total assets Rs m76,59125,400 301.5%  
Interest coverage x2.7311.7 0.9%   
Debt to equity ratio x1.00-  
Sales to assets ratio x0.40.9 44.2%   
Return on assets %5.111.8 43.2%  
Return on equity %7.317.1 42.6%  
Return on capital %8.226.9 30.3%  
Exports to sales %48.124.5 196.5%   
Imports to sales %14.528.0 51.7%   
Exports (fob) Rs m15,1925,801 261.9%   
Imports (cif) Rs m4,5656,627 68.9%   
Fx inflow Rs m16,6127,145 232.5%   
Fx outflow Rs m5,2926,846 77.3%   
Net fx Rs m11,320299 3,785.9%   
CASH FLOW
From Operations Rs m7173,226 22.2%  
From Investments Rs m-22,284-1,555 1,433.1%  
From Financial Activity Rs m29,488-1,818 -1,622.0%  
Net Cashflow Rs m8,073-147 -5,491.8%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 37.8 14.4 262.5%  
FIIs % 8.6 14.6 58.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 10.5 246.7%  
Shareholders   56,241 15,184 370.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SHASUN PHARMA  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 23, 2017 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS